The adaptive response in radiobiology: evolving insights and implications

Environmental Health Perspectives
S Wolff

Abstract

The first of the regularly reproducible experiments to show that very low doses of ionizing radiation, like very low doses of chemical agents, could induce mechanisms whereby cells become better fit to cope with subsequent exposures to high doses were carried out on the induction of chromosome aberrations in cultures of human lymphocytes. If cells that had been exposed to a very low dose (1 cGy) of X rays were subsequently exposed to a relatively high dose (1 Gy), approximately half as many chromosome breaks were induced. Subsequent experiments showed that this adaptive response to low doses requires a certain minimal dose before it becomes active; occurs only within a relatively small window of dose; is dose-rate dependent; and depends on the genetic constitution of the people or animals exposed, with some being unresponsive. It was further shown that the response to the low-dose preexposure was not instantaneous but took approximately 4 to 6 hr to become fully active, and could be prevented if during this period protein synthesis was inhibited, i.e., a necessary protein (enzyme) was being induced. In fact, subsequent experiments with two-dimensional gel electrophoresis showed new proteins in cells irradiated with 1 to 2 cGy. ...Continue Reading

References

Mar 1, 1989·Mutation Research·A Bosi, G Olivieri
Mar 1, 1989·Mutation Research·K SankaranarayananA T Natarajan
Jan 1, 1988·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·S WolffA Michaeli
Jan 1, 1983·Basic Life Sciences·L Samson, J L Schwartz
Aug 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D A BoothmanS W Lee
Nov 4, 1996·Mutation Research·D Bhattacharjee

❮ Previous
Next ❯

Citations

Mar 29, 2014·PloS One·Sandrine LacosteTimothy R O'Connor
Nov 5, 2013·Antioxidants & Redox Signaling·Aris T Alexandrou, Jian Jian Li
Aug 31, 2013·Journal of Cancer Research and Clinical Oncology·Nadire DuruJian Jian Li
Jan 21, 2014·Mutation Research. Genetic Toxicology and Environmental Mutagenesis·Hamid KalantariHamid Gourabi
May 17, 2014·Seminars in Nuclear Medicine·Antone L Brooks, Lawrence T Dauer
Mar 1, 2012·Molecular Biology Reports·M Ahmad ChaudhryEdouard I Azzam
Jan 28, 2005·The British Journal of Radiology·L E Feinendegen
Nov 24, 2012·The British Journal of Radiology·D J ShahD J Wilson
Nov 30, 2006·Radiation and Environmental Biophysics·Soile Tapio, Vesna Jacob
Jan 15, 2008·Radiation and Environmental Biophysics·Otilia Nuta, Firouz Darroudi
Aug 22, 2012·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·M ArenasJ Panés
May 3, 2000·Proceedings of the National Academy of Sciences of the United States of America·M M Vilenchik, A G Knudson
Oct 24, 2001·Environmental Health Perspectives·C de Brouwer, R Lagasse
Nov 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·David J BrennerMarco Zaider
Jun 10, 2008·Physics in Medicine and Biology·X George XuHarald Paganetti
Aug 22, 2008·Croatian Medical Journal·Marija GamulinVera Garaj-Vrhovac
Aug 6, 2002·Mutation Research·Karen J SorensenJames D Tucker
Apr 29, 2005·Uchū Seibutsu Kagaku·Hideki MatsumotoTakeo Ohnishi
Mar 13, 2009·International Journal of Radiation Biology·Claudia A GrilloAlba M Guerci
Mar 10, 2006·International Journal of Radiation Biology·P K AvtiS C Sharma
Jan 26, 2016·Health Physics·Edouard I AzzamSonia M de Toledo
Mar 28, 2013·Oxidative Medicine and Cellular Longevity·Aleksei V ErmakovNatalya N Veiko
Jan 26, 2012·Mutation Research·Carmel Mothersill, Colin Seymour
Aug 24, 2010·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·A LisbonaJ-L Lagrange
Jan 19, 2010·Mutation Research·Dietrich Averbeck
Jul 21, 2009·International Journal of Radiation Oncology, Biology, Physics·Hengshan ZhangLurong Zhang
Jun 23, 2009·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·M Tubiana
Feb 10, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Maurice Tubiana
Dec 7, 2007·Journal of Environmental Radioactivity·Lorna A RyanCarmel E Mothersill
Oct 31, 2007·Free Radical Biology & Medicine·Kazi Mokim Ahmed, Jian Jian Li
Mar 12, 2016·Redox Biology·Lingzhi BaoWei Han
Oct 9, 2007·Mutation Research·Fumio YatagaiFumio Hanaoka
Sep 29, 2015·Scientific Reports·Lei ZhaoYeqing Sun
Dec 21, 2007·Environmental and Molecular Mutagenesis·Michael KilemadeDouglas Boreham
Nov 9, 2004·Mutation Research·Philip J CoatesEric G Wright

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.